Ependion
114,8
SEK
-13,68 %
Mindre end 1K følgere
EPEN
NASDAQ Stockholm
Hardware Manufacturer
Technology
Overview
Ownership
Investor consensus
-13,68%
-18,47%
+10,6%
+18,23%
+13,21%
+8,92%
+79,66%
+205,73%
+339,34%
Ependion operates in the technology industry and focuses on the development and manufacturing of electronic systems and components. The company's products are used in various sectors, including industry, medical technology and defense. The business is international and targets companies and institutions globally. Ependion was founded in 1981 and is headquartered in Malmö.
Læs mereMarkedsværdi
3,37 mia. SEK
Aktieomsætning
5,56 mio. SEK
Omsætning
2,26 mia.
EBIT %
11,11 %
P/E
21,06
Udbytteafkast, %
1,09 %
Finanskalender
29.4
2025
Delårsrapport Q1'25
13.5
2025
Generalforsamling '25
14.5
2025
Årligt udbytte
Alle
Selskabspræsentationer
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper

Ependion, Audiocast with teleconference, Q1'25
Ependion AB: Interim Report January-March 2025: Progressive future investments and cost savings in uncertain times
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Ependion AB issues class C shares and convert class C shares into ordinary shares
Ependion AB: Invitation to presentation of Ependion's Three-Month interim report 2025
Redeye: Ependion - Welotec – a good strategic fit
Notice of the AGM of Ependion AB

Audiocast with teleconference, Press Conference, April 2025
Carnegie Access: Ependion: Adds 12% revenue through acquisition in the energy segment
Ependion AB: Ependion strengthens its position in the energy sector through acquisition
Carnegie Access: Ependion: Highlights from Carnegie’s Micro & Small Cap Day
Ependion AB: Nomination Committee Board Proposals for 2025
Carnegie Access: Ependion: Interview - Cautiously optimistic about 2025
Redeye: Ependion - Welcome recovery in Q4
Carnegie Access: Ependion: Order intake beat gives cause for optimism
Carnegie Access: Ependion: Best order intake since Q2(23) – Q4 first take
